Yi-Hsuan Lin , Chia-Hung Lin , Yu-Chih Lin , Yu-Yao Huang , An-Shun Tai , Shih-Chen Fu , Sheng-Hsuan Lin
{"title":"“钠-葡萄糖共转运蛋白2抑制剂与以肠促胰岛素为基础的治疗相比,可降低糖尿病足病患者心力衰竭住院风险和截肢率:一项全国性人群研究”的更正[内分泌实践30(2024)424-430]。","authors":"Yi-Hsuan Lin , Chia-Hung Lin , Yu-Chih Lin , Yu-Yao Huang , An-Shun Tai , Shih-Chen Fu , Sheng-Hsuan Lin","doi":"10.1016/j.eprac.2025.01.006","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":"31 4","pages":"Page 556"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430]\",\"authors\":\"Yi-Hsuan Lin , Chia-Hung Lin , Yu-Chih Lin , Yu-Yao Huang , An-Shun Tai , Shih-Chen Fu , Sheng-Hsuan Lin\",\"doi\":\"10.1016/j.eprac.2025.01.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11682,\"journal\":{\"name\":\"Endocrine Practice\",\"volume\":\"31 4\",\"pages\":\"Page 556\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1530891X25000308\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X25000308","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430]
期刊介绍:
Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.